References
- Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceus and Schimmelpenning syndrome. Nat Genet 2012;44:783-7. https://doi.org/10.1038/ng.2316
- Shaw RJ and Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006;441:424-30. https://doi.org/10.1038/nature04869
- Aslam A, Salam A, Griffiths CE, McGrath JA. Naevus sebaceus: a mosaic RASopathy. Clin Exp Dermatol 2014;39:1-6. https://doi.org/10.1111/ced.12209
- Levinsohn JL, Tian LC, Boyden LM, McNiff JM, Narayan D, Loring ES, et al. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus. J Invest Dermatol 2013;133:827-30. https://doi.org/10.1038/jid.2012.379
- Happle R. Nevus sebaceus is a mosaic RASopathy. J Invest Dermatol 2013;133:597-600. https://doi.org/10.1038/jid.2012.447
- Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006;38:331-6. https://doi.org/10.1038/ng1748
- Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 2005;37:1038-40. https://doi.org/10.1038/ng1641
- Brandling-Bennett HA Morel KD. Epidermal nevi. Pediatr Clin North Am 2010;57:1177-98. https://doi.org/10.1016/j.pcl.2010.07.004
- Sun BK, Saggini A, Sarin KY, Kim J, Benjamin L, LeBoit PE, et al. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol 2013;133:824-7. https://doi.org/10.1038/jid.2012.377
Cited by
- Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis vol.90, pp.4, 2015, https://doi.org/10.1111/cge.12775